BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

636 related articles for article (PubMed ID: 27896442)

  • 1. Regional citrate anticoagulation for continuous renal replacement therapy in children.
    Rico MP; Fernández Sarmiento J; Rojas Velasquez AM; González Chaparro LS; Gastelbondo Amaya R; Mulett Hoyos H; Tibaduiza D; Quintero Gómez AM
    Pediatr Nephrol; 2017 Apr; 32(4):703-711. PubMed ID: 27896442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional citrate versus systemic heparin anticoagulation for continuous renal replacement therapy in critically ill children.
    Sık G; Demirbuga A; Annayev A; Citak A
    Int J Artif Organs; 2020 Apr; 43(4):234-241. PubMed ID: 31856634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Citrate versus heparin anticoagulation in continuous renal replacement therapy in small children.
    Raymakers-Janssen PAMA; Lilien M; van Kessel IA; Veldhoen ES; Wösten-van Asperen RM; van Gestel JPJ
    Pediatr Nephrol; 2017 Oct; 32(10):1971-1978. PubMed ID: 28578542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Randomized Controlled Trial of Regional Citrate Versus Regional Heparin Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Adults.
    Gattas DJ; Rajbhandari D; Bradford C; Buhr H; Lo S; Bellomo R
    Crit Care Med; 2015 Aug; 43(8):1622-9. PubMed ID: 25853591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial.
    Schilder L; Nurmohamed SA; Bosch FH; Purmer IM; den Boer SS; Kleppe CG; Vervloet MG; Beishuizen A; Girbes AR; Ter Wee PM; Groeneveld AB;
    Crit Care; 2014 Aug; 18(4):472. PubMed ID: 25128022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Citrate anticoagulation for continuous renal replacement therapy in the critically ill.
    Oudemans-van Straaten HM
    Blood Purif; 2010; 29(2):191-6. PubMed ID: 20093826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-centre evaluation of anticoagulation in patients receiving continuous renal replacement therapy (CRRT).
    Brophy PD; Somers MJ; Baum MA; Symons JM; McAfee N; Fortenberry JD; Rogers K; Barnett J; Blowey D; Baker C; Bunchman TE; Goldstein SL
    Nephrol Dial Transplant; 2005 Jul; 20(7):1416-21. PubMed ID: 15855212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy: a meta-analysis of randomized controlled trials.
    Wu MY; Hsu YH; Bai CH; Lin YF; Wu CH; Tam KW
    Am J Kidney Dis; 2012 Jun; 59(6):810-8. PubMed ID: 22226564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal replacement therapy and anticoagulation.
    Brandenburger T; Dimski T; Slowinski T; Kindgen-Milles D
    Best Pract Res Clin Anaesthesiol; 2017 Sep; 31(3):387-401. PubMed ID: 29248145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Regional Citrate Anticoagulation vs Systemic Heparin Anticoagulation During Continuous Kidney Replacement Therapy on Dialysis Filter Life Span and Mortality Among Critically Ill Patients With Acute Kidney Injury: A Randomized Clinical Trial.
    Zarbock A; Küllmar M; Kindgen-Milles D; Wempe C; Gerss J; Brandenburger T; Dimski T; Tyczynski B; Jahn M; Mülling N; Mehrländer M; Rosenberger P; Marx G; Simon TP; Jaschinski U; Deetjen P; Putensen C; Schewe JC; Kluge S; Jarczak D; Slowinski T; Bodenstein M; Meybohm P; Wirtz S; Moerer O; Kortgen A; Simon P; Bagshaw SM; Kellum JA; Meersch M;
    JAMA; 2020 Oct; 324(16):1629-1639. PubMed ID: 33095849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical impact of regional citrate anticoagulation in continuous renal replacement therapy in critically ill patients.
    Huguet M; Rodas L; Blasco M; Quintana LF; Mercadal J; Ortiz-Pérez JT; Rovira I; Poch E
    Int J Artif Organs; 2017 Nov; 40(12):676-682. PubMed ID: 28862718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: a meta-analysis with trial sequential analysis of randomized controlled trials.
    Liu C; Mao Z; Kang H; Hu J; Zhou F
    Crit Care; 2016 May; 20(1):144. PubMed ID: 27176622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system.
    Bagshaw SM; Laupland KB; Boiteau PJ; Godinez-Luna T
    J Crit Care; 2005 Jun; 20(2):155-61. PubMed ID: 16139156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Citrate anticoagulation during continuous renal replacement therapy in pediatric critical care.
    Davis TK; Neumayr T; Geile K; Doctor A; Hmeil P
    Pediatr Crit Care Med; 2014 Jun; 15(5):471-85. PubMed ID: 24777299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional citrate anticoagulation for continuous renal replacement therapy in pediatric patients with liver failure.
    Rodriguez K; Srivaths PR; Tal L; Watson MN; Riley AA; Himes RW; Desai MS; Braun MC; Akcan Arikan A
    PLoS One; 2017; 12(8):e0182134. PubMed ID: 28792509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional citrate anticoagulation in cardiac surgery patients at high risk of bleeding: a continuous veno-venous hemofiltration protocol with a low concentration citrate solution.
    Morabito S; Pistolesi V; Tritapepe L; Zeppilli L; Polistena F; Strampelli E; Pierucci A
    Crit Care; 2012 Jun; 16(3):R111. PubMed ID: 22738289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional citrate anticoagulation using a citrate-based substitution solution for continuous venovenous hemofiltration in cardiac surgery patients.
    Thoenen M; Schmid ER; Binswanger U; Schuepbach R; Aerne D; Schmidlin D
    Wien Klin Wochenschr; 2002 Feb; 114(3):108-14. PubMed ID: 12060967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk.
    Kalb R; Kram R; Morgera S; Slowinski T; Kindgen-Milles D
    Ther Apher Dial; 2013 Apr; 17(2):202-12. PubMed ID: 23551677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bivalirudin versus unfractionated heparin for prevention of hemofilter occlusion during continuous renal replacement therapy.
    Kiser TH; MacLaren R; Fish DN; Hassell KL; Teitelbaum I
    Pharmacotherapy; 2010 Nov; 30(11):1117-26. PubMed ID: 20973685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study.
    Monchi M; Berghmans D; Ledoux D; Canivet JL; Dubois B; Damas P
    Intensive Care Med; 2004 Feb; 30(2):260-265. PubMed ID: 14600809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.